1. null
    Petra Hudler et al, 2017 CrossRef
  2. Role of Δ133p53 isoform in NF-κB inhibitor PDTC-mediated growth inhibition of MKN45 gastric cancer cells
    Hong-Mei Zhang et al, 2017, WJG CrossRef
  3. Comparing intestinal versus diffuse gastric cancer using a PEFF-oriented proteomic pipeline
    Helisa Helena Wippel et al, 2017, Journal of Proteomics CrossRef
  4. Multimodality Treatment Including Triplet Regimen as First-Line Chemotherapy May Improve Prognosis of Serum AFP-Elevated Gastric Cancer with Liver Metastasis
    Yakun Wang et al, 2017, Gastroenterology Research and Practice CrossRef
  5. Surgery for metastases for esophageal-gastric cancer in the real world: data from the AGAMENON national registry
    Alberto Carmona-Bayonas et al, 2018, European Journal of Surgical Oncology CrossRef
  6. Surgical treatment outcomes of patients with T1-T2 gastric cancer: does the age matter when excellent treatment results are expected?
    Rimantas Bausys et al, 2018, World J Surg Onc CrossRef
  7. Loss of ARID1A expression is associated with poor prognosis in patients with gastric cancer
    Yi Ping Zhu et al, 2018, Human Pathology CrossRef
  8. Prognostic value of the cancer oncogene Kelch-like 6 in gastric cancer
    J. Deng et al, 2017, Br J Surg CrossRef
  9. Current challenges in gastric cancer surgery: European perspective.
    Karol Rawicz-Pruszyński et al, 2018, Surgical Oncology CrossRef
  10. Tumor-associated macrophages (TAMs) as biomarkers for gastric cancer: A review
    Meri R. Räihä et al, 2018, Chronic Diseases and Translational Medicine CrossRef
  11. null
    Neelam Khetpal et al, 2018 CrossRef
  12. Diverse Expression of IL-32 in Diffuse and Intestinal Types of Gastric Cancer
    Mladen Pavlovic et al, 2018, Gastroenterology Research and Practice CrossRef
  13. Resolving gastric cancer aetiology: an update in genetic predisposition
    Paul C Lott et al, 2018, The Lancet Gastroenterology & Hepatology CrossRef
  14. Signet ring cell component, not the Lauren subtype, predicts poor survival: an analysis of 198 cases of gastric cancer
    Vladimir Galvão de Aguiar et al, 2019, Future Oncology CrossRef
  15. Pediatric Gastric Adenocarcinoma: a National Cancer Data Base Review
    Robert A. Tessler et al, 2019, Journal of Pediatric Surgery CrossRef
  16. Intestinal and diffuse gastric cancer: a retrospective study comparing primary sites
    Brinda Rao Korivi et al, 2019, Clinical Imaging CrossRef
  17. Randomised phase II trial comparing four front-line doublets in Asian patients with metastatic gastric cancer
    Chan Kim et al, 2019, European Journal of Cancer CrossRef
  18. Ligaments and Lymphatic Pathways in Gastric Adenocarcinoma
    Jennifer J. Young et al, 2019, RadioGraphics CrossRef
  19. Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry
    Paula Jiménez Fonseca et al, 2017, Br J Cancer CrossRef
  20. Epigenetic changes in gastric cancer induction by Helicobacter pylori
    Bahman Yousefi et al, 2019, J Cell Physiol CrossRef
  21. Association of the −181 G→A polymorphism in the MMP-7 gene promoter and gastric cancer: A case-control study
    Majid Tafrihi et al, 2019, Meta Gene CrossRef
  22. null
    Kaiming Xue et al, 2019 CrossRef
  23. Rare Presentation of Gastroesophageal Carcinoma with Rectal Metastasis: A Case Report
    Jasbir Makker et al, 2016, Am J Case Rep CrossRef
  24. signeR: an empirical Bayesian approach to mutational signature discovery
    Rafael A. Rosales et al, 2017, Bioinformatics CrossRef
  25. Dissection of gastric cancer heterogeneity for precision oncology
    Shamaine Wei Ting Ho et al, 2019, Cancer Sci CrossRef
  26. Multiscale network analysis reveals molecular mechanisms and key regulators of the tumor microenvironment in gastric cancer
    Won‐Min Song et al, 2019, Int. J. Cancer CrossRef
  27. Calprotectin (S100A8/S100A9)-induced cytotoxicity and apoptosis in human gastric cancer AGS cells: Alteration in expression levels of Bax, Bcl-2, and ERK2
    F Shabani et al, 2020, Hum Exp Toxicol CrossRef
  28. Immunological Aspects of the Tumor Microenvironment and Epithelial-Mesenchymal Transition in Gastric Carcinogenesis
    Jacek Baj et al, 2020, IJMS CrossRef
  29. Practical guidance for the evaluation of disease progression and the decision to change treatment in patients with advanced gastric cancer receiving chemotherapy
    Satoru Iwasa et al, 2020, Int J Clin Oncol CrossRef
  30. Case report: acute abdominal pain in a 37-year-old patient and the consequences for his family
    Elisabeth Niemeyer et al, 2020, BMC Gastroenterol CrossRef
  31. ¿Son los patrones radiológicos concordantes con la anatomía patológica en el cáncer gástrico calcificado?
    S. Navarro-Martínez et al, 2020, Revista de Gastroenterología de México CrossRef
  32. Distinct molecular subtypes of gastric cancer: from Laurén to molecular pathology
    Magdalena Cisło et al, 2018, Oncotarget CrossRef
  33. Maspin suppresses cell invasion and migration in gastric cancer through inhibiting EMT and angiogenesis via ITGB1/FAK pathway
    Ning Wang et al, 2020, Human Cell CrossRef
  34. Non-coding RNAs underlying chemoresistance in gastric cancer
    Arash Poursheikhani et al, 2020, Cell Oncol. CrossRef
  35. The Multi-Disciplinary Management of Gastric Adenocarcinoma: The Retrospective Analysis of Outcomes of Patients Treated at Vajira Hospital
    , 2020, J Med Assoc Thai CrossRef
  36. Evaluation of the Effects of Valproic Acid Treatment on Cell Survival and Epithelial-Mesenchymal Transition-Related Features of Human Gastric Cancer Cells
    Mehrnaz Jahani et al, 2020, J Gastrointest Canc CrossRef
  37. COL12A1, a novel potential prognostic factor and therapeutic target in gastric cancer
    Xiaoxia Jiang et al, 2019, Mol Med Report CrossRef
  38. Prognostic significance of mRNA expression of CASPs in gastric cancer
    Zixiang Wang et al, 2019, Oncol Lett CrossRef
  39. Regulation of lncRNA PVT1 on miR-125 in metastasis of gastric cancer cells.
    Jiatai Niu et al, 2020, Oncol Lett CrossRef
  40. A Molecular Stratification of Chilean Gastric Cancer Patients with Potential Clinical Applicability
    Mauricio P. Pinto et al, 2020, Cancers CrossRef
  41. Expression patterns of seven key genes, including β-catenin, Notch1, GATA6, CDX2, miR-34a, miR-181a and miR-93 in gastric cancer
    Narjes Jafari et al, 2020, Sci Rep CrossRef
  42. Prognostic Significances of NEDD-9 and FOXL-1 Expression in Intestinal Type Gastric Carcinoma: an Immunohistochemical Study.
    Noha F Elaidy et al, 2021, J Gastrointest Cancer CrossRef
  43. Pathways of Gastric Carcinogenesis, Helicobacter pylori Virulence and Interactions with Antioxidant Systems, Vitamin C and Phytochemicals
    James W. T. Toh et al, 2020, IJMS CrossRef
  44. Update, validation and comparison of three different clinicopathological scores for patients with resected gastric cancer: A western experience
    Cristina Díaz del Arco et al, 2020, Annals of Diagnostic Pathology CrossRef
  45. null
    Vigneshwar Suriya Prakash Sinnarasan et al, 2020 CrossRef
  46. Decoding Genes: Current Update on Radiogenomics of Select Abdominal Malignancies
    Venkata S. Katabathina et al, 2020, RadioGraphics CrossRef
  47. The changing face of gastric cancer: epidemiologic trends and advances in novel therapies
    Raghav Chandra et al, 2020, Cancer Gene Ther CrossRef
  48. The metastatic pattern of intestinal and diffuse type gastric carcinoma – A Dutch national cohort study
    W.J. Koemans et al, 2020, Cancer Epidemiology CrossRef
  49. LncRNA UCA1 Enhances Cisplatin Resistance by Regulating CYP1B1-mediated Apoptosis via miR-513a-3p in Human Gastric Cancer
    Haidong Cheng et al, 2021, CMAR CrossRef
  50. Are radiologic patterns consistent with pathologic anatomy in calcified gastric cancer?
    S. Navarro-Martínez et al, 2021, Revista de Gastroenterología de México (English Edition) CrossRef
  51. In vivo assessment of Lauren classification for gastric adenocarcinoma using diffusion MRI with a fractional order calculus model
    M. Muge Karaman et al, 2021, Eur Radiol CrossRef
  52. Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry
    Felipe Alvarez-Manceñido et al, 2021, Gastric Cancer CrossRef
  53. Predictors and significance of histologic response to neoadjuvant therapy for gastric cancer
    Ataollah Rajabnejad et al, 2021, J Surg Oncol CrossRef
  54. miR-34a mimic or pre-mir-34a, which is the better option for cancer therapy? KatoIII as a model to study miRNA action in human gastric cancer cells
    Narjes Jafari et al, 2021, Cancer Cell Int CrossRef
  55. Prediction of overall survival and response to immune checkpoint inhibitors: An immune-related signature for gastric cancer
    Zheng Wang et al, 2021, Translational Oncology CrossRef
  56. Single-cell sequencing technology in tumor research
    Xue Bai et al, 2021, Clinica Chimica Acta CrossRef
  57. How to Best Exploit Immunotherapeutics in Advanced Gastric Cancer: Between Biomarkers and Novel Cell-Based Approaches
    Michele Ghidini et al, 2021, JCM CrossRef
  58. null
    Israa Abdullah Malli, 2021 CrossRef
  59. Helicobacter pylori Outer Membrane Vesicles and Extracellular Vesicles from Helicobacter pylori-Infected Cells in Gastric Disease Development
    María Fernanda González et al, 2021, IJMS CrossRef
  60. Diagnostic and therapeutic potencies of miR-18a-5p in mixed-type gastric adenocarcinoma.
    Li Wang et al, 2021, J Cell Biochem CrossRef
  61. The Comparison of mDCF and mFOLFOX-6 as First-Line Treatment in Metastatic Gastric Cancer
    Yusuf Acikgoz et al, 2021 CrossRef
  62. Comparison of endoscopic gastritis based on Kyoto classification between diffuse and intestinal gastric cancer
    Osamu Toyoshima et al, 2021, WJGE CrossRef
  63. Inherited Predisposition to Gastric Cancer
    Sheila D. Rustgi et al, 2021, Gastrointestinal Endoscopy Clinics of North America CrossRef
  64. Transcriptome Analysis and the Prognostic Role of NUDC in Diffuse and Intestinal Gastric Cancer
    Sang-Ho Jeong et al, 2021, Technol Cancer Res Treat CrossRef
  65. Long noncoding RNA CYTOR triggers gastric cancer progression by targeting miR-103/RAB10
    Fang Wei et al, 2021 CrossRef
  66. Clinical Significance of Peritoneal Fluid Examination for Free Cancer Cells in Patients Qualified for Surgery for Gastric Cancer
    Sławomir Cieśla et al, 2021, Front. Surg. CrossRef
  67. Sp1-Induced FNBP1 Drives Rigorous 3D Cell Motility in EMT-Type Gastric Cancer Cells
    Bo Kyung Yoon et al, 2021, IJMS CrossRef
  68. Cutaneous Metastasis of Signet Ring Cell Carcinoma: An Unusual Case Report
    Shekhar N Pradhan et al, 2021, J Skin Stem Cell CrossRef
  69. Differential Expression of COL1A1, COL1A2, COL6A3, and SULF1 as Prognostic Biomarkers in Gastric Cancer
    Yan Hu et al, 2021, IJGM CrossRef
  70. Komplette Response nach neoadjuvanter Therapie beim Magenkarzinom: Implikationen für die Chirurgie
    Giovanni Capovilla et al, 2021, Chirurg CrossRef
  71. Imaging of Gastric Carcinomatosis
    Raquel Saiz Martínez et al, 2021, JCM CrossRef
  72. Computed tomographic pneumogastrography in determining the types of gastric cancer according to the Lauren classification
    A. D. Amelina et al, 2021, Malignant Tumours CrossRef
  73. Dietary Intake of Soy Products, Vegetables, and Dairy Products and Gastric Cancer Survival according to Histological Subtype: A Long-term Prospective Cohort Study
    Jung Hyun Kwak et al, 2021, J Gastric Cancer CrossRef
  74. Phosphoserine phosphatase as a prognostic biomarker in patients with gastric cancer and its potential association with immune cells
    Ma-Yan Huang et al, 2022, BMC Gastroenterol CrossRef
  75. Association Between DCE-MRI Perfusion Histogram Parameters and EGFR and VEGF Expressions in Different Lauren Classifications of Advanced Gastric Cancer
    Zhiheng Li et al, 2022, Pathol. Oncol. Res. CrossRef
  76. Trimodality treatment in gastric and gastroesophageal junction cancers: Current approach and future perspectives
    Nikolaos Charalampakis et al, 2022, WJGO CrossRef
  77. CT-based radiomics nomograms for preoperative prediction of diffuse-type and signet ring cell gastric cancer: a multicenter development and validation cohort.
    Tao Chen et al, 2022, J Transl Med CrossRef
  78. null
    Rachel Sexton et al, 2022 CrossRef
  79. Response to neoadjuvant chemotherapy and survival in molecular subtypes of resectable gastric cancer: a post hoc analysis of the D1/D2 and CRITICS trials
    Hedde D. Biesma et al, 2022, Gastric Cancer CrossRef
  80. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
    Jaffer A. Ajani et al, 2022 CrossRef
  81. Gastric carcinoma's primary presentation as multiple cutaneous nodules throughout the body
    Amir A Bajoghli et al, 2022, Cancer Treatment and Research Communications CrossRef
  82. CDH1 Germline Variants in a Tunisian Cohort with Hereditary Diffuse Gastric Carcinoma
    Jihenne Ben Aissa-Haj et al, 2022, Genes CrossRef
  83. Impact of Selected Serum Factors on Metastatic Potential of Gastric Cancer Cells
    Marta Tkacz et al, 2022, Diagnostics CrossRef
  84. Ubiquitylation of cyclin C by HACE1 regulates cisplatin‐associated sensitivity in gastric cancer
    Hong‐yue Jiang et al, 2022, Clinical & Translational Med CrossRef
  85. Tumor Molecular Profiling in Hispanics: Moving Towards Precision Oncology and Health Equity
    Sariemma Mendez Rodríguez et al, 2022, J. Racial and Ethnic Health Disparities CrossRef
  86. Clinicopathological differences, risk factors and prognostic scores for western patients with intestinal and diffuse-type gastric cancer
    Cristina Díaz del Arco et al, 2022, WJGO CrossRef
  87. Survival of Stomach Cancer Patients in Western Kazakhstan: a Registry-Based Study
    Anar B. Tulyayeva et al, 2021, Ekologiya cheloveka (Human Ecology) CrossRef
  88. Synaptotagmin 11 scaffolds MKK7–JNK signaling process to promote stem-like molecular subtype gastric cancer oncogenesis
    Bo-Kyung Kim et al, 2022, J Exp Clin Cancer Res CrossRef
  89. Genomically Silent Refractory Gastric Cancer in a Young Patient Exhibits Overexpression of CXCL5
    Jonathan Hernandez et al, 2022, Current Oncology CrossRef
  90. DNA Methylation of HOXA11 Gene as Prognostic Molecular Marker in Human Gastric Adenocarcinoma
    Povilas Ignatavicius et al, 2022, Diagnostics CrossRef
  91. Global burden of gastric cancer in adolescents and young adults: estimates from GLOBOCAN 2020
    J. Li et al, 2022, Public Health CrossRef
  92. Gastric cancer incidence, mortality and burden in adolescents and young adults: a time-trend analysis and comparison among China, South Korea, Japan and the USA
    Si Lin Wu et al, 2022, BMJ Open CrossRef
  93. lncRNA HIT000218960 enhances resistance to 5‑fluorouracil by promoting HMGA2 and activating the AKT/mTOR/P70S6K pathway in gastric cancer cells
    Li Bai et al, 2022, Exp Ther Med CrossRef
  94. The Associations of Dietary Intake of High Sodium and Low Zinc with Gastric Cancer Mortality: A Prospective Cohort Study in Korea
    Jung Hyun Kwak et al, 2022, Nutrition and Cancer CrossRef
  95. Flavonoids-Rich Plant Extracts Against Helicobacter pylori Infection as Prevention to Gastric Cancer
    Renaly Ivyna de Araújo Rêgo et al, 2022, Front. Pharmacol. CrossRef
  96. Myoferlin disturbs redox equilibrium to accelerate gastric cancer migration
    Hailong Shi et al, 2022, Front. Oncol. CrossRef
  97. Incorporating Immunotherapy in the Management of Gastric Cancer: Molecular and Clinical Implications
    Alessandro Agnarelli et al, 2022, Cancers CrossRef
  98. Somatic Mutational Landscape in Mexican Patients: CDH1 Mutations and chr20q13.33 Amplifications Are Associated with Diffuse-Type Gastric Adenocarcinoma
    Dennis Cerrato-Izaguirre et al, 2022, IJMS CrossRef
  99. Construction of a Cuprotosis-Related Gene-Based Model to Improve the Prognostic Evaluation of Patients with Gastric Cancer
    Chunyan Han et al, 2022, Journal of Immunology Research CrossRef
  100. Adversarial attacks and adversarial robustness in computational pathology
    Narmin Ghaffari Laleh et al, 2022, Nat Commun CrossRef
  101. Dietary zinc intake and mortality in patients with intestinal-type gastric cancer: A prospective cohort study in Korea
    Jung Hyun Kwak et al, 2022, Front. Oncol. CrossRef
  102. Adenocarcinoma gástrico: revisión del TNM y de las vías de diseminación
    P. López Sala et al, 2022, Radiología CrossRef
  103. Association of Dietary Antioxidant Vitamin Intake and Gastric Cancer Risk According to Smoking Status and Histological Subtypes of Gastric Cancer: A Case-Control Study in Korea
    Shin Ah Kim et al, 2022, Nutrition and Cancer CrossRef
  104. Safety of pylorus-preserving gastrectomy for gastric cancer combined with antral high-risk lesions: a comparison with endoscopic submucosal dissection
    Jinju Choi et al, 2022, Surg Endosc CrossRef
  105. LNCAROD promotes the proliferation and migration of gastric cancer: a bioinformatics analysis and experimental validation
    Sara Ansari et al, 2023, Funct Integr Genomics CrossRef